Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

Clinical trial NCT07116928 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07116928
Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

T2DM (Type 2 Diabetes Mellitus)CKD - Chronic Kidney Disease

Start date: 2025-11-30
Primary completion: 2031-10-30
Enrollment: 1244

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.